20/20 Biolabs, Inc. (AIDX)
0.5139
-0.04
(-7.29%)
USD |
NASDAQ |
Aug 24, 16:00
0.5139
0.00 (0.00%)
After-Hours: 20:00
20/20 Biolabs EPS Diluted (Quarterly) : -0.2247 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2247 |
| March 31, 2026 | -0.2031 |
| December 31, 2025 | -0.1252 |
| September 30, 2025 | -0.17 |
| March 31, 2025 | -0.0732 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.26 |
| September 30, 2024 | -0.39 |
| June 30, 2023 | -0.36 |
| March 31, 2023 | -0.42 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sanara MedTech, Inc. | -0.0523 |
| Intelligent Bio Solutions, Inc. | -1.345 |
| Anteris Technologies Global Corp. | -0.2989 |
| Quest Diagnostics, Inc. | 2.848 |
| Labcorp Holdings, Inc. | 3.643 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.506M |
| Revenue (Quarterly) | 0.7306M |
| Total Expenses (Quarterly) | 2.237M |
| Enterprise Value | 4.356M |
| Gross Profit Margin (Quarterly) | 41.71% |
| Profit Margin (Quarterly) | -206.2% |
| Earnings Yield | -140.7% |